baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC DIS.CERT. 12/24 PFE/ DE000HC8R8V7 /

6/5/2024 3:46:46 PM	Chg.+0.010	Bid3:51:21 PM	Ask3:51:21 PM	Underlying	Strike price	Expiration date	Option type
23.790EUR	+0.04%	23.760 Bid Size: 2,000	23.770 Ask Size: 2,000	PFIZER INC. D...	- -	12/31/2024	Call

GlobeNewswire 2:00 PM Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts

GlobeNewswire 7:00 AM Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Co...

GlobeNewswire 6/4 Alation Deepens Integration with Snowflake to Improve Data Quality and Deliver AI-Ready Data

GlobeNewswire 6/4 Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June

GlobeNewswire 6/3 Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases

GlobeNewswire 5/16 Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combinatio...

TeleTrader 5/1 Pfizer's Q1 revenue drops 20% to $14.9 billion

GlobeNewswire 4/30 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...

GlobeNewswire 3/22 Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous ...

GlobeNewswire 3/20 Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook

GlobeNewswire 3/7 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 3/7 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 3/5 LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd...

GlobeNewswire 2/28 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 2/28 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 2/27 Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment t...

GlobeNewswire 2/23 Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market

GlobeNewswire 2/20 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 2/16 ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Befo...

GlobeNewswire 2/11 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

GlobeNewswire 2/8 ROSEN, A RANKED AND LEADING FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Importan...

GlobeNewswire 2/6 Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment o...

GlobeNewswire 2/3 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...

TeleTrader 1/30 Pfizer posts Q4 revenue of $14B, reaffirms guidance

GlobeNewswire 1/26 ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadl...

UC DIS.CERT. 12/24 PFE/ DE000HC8R8V7 /

If you wish to receive reply to your feedback, please provide your email address.